DMD: pharmacological trials-3

  • Rim4DMD : A phase Ib, open label study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending oral doses of Rimeporide in patients with Duchenne Muscular Dystrophy
  • Italfarmaco: Randomised, Double Blind, Placebo Controlled, Multicentre Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy

 

Acronym

Rim4DMD

Italfarmaco

Study type
BMR BMR
Trial type
Multicentre trial Multicentre trial
Intervention Rimeporide Givinostat vs Placebo
Principal investigator Teresa Gidaro Teresa Gidaro
Sponsor Esperare Fundation Itlafarmaco
Fundings Esperare Itlafarmaco
Study status Ongoing Ongoing
Recruitment status Ongoing Ongoing
Population Child Child
Contact t.gidaro@institut-myologie.org t.gidaro@institut-myologie.org
+ infos on clinicaltrials.gov + infos on clinicaltrials.gov